BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17340621)

  • 1. Bystander killing of breast cancer MCF-7 cells by MDA-MB-231 cells exposed to 5-fluorouracil is mediated via Fas.
    Chhipa RR; Bhat MK
    J Cell Biochem; 2007 May; 101(1):68-79. PubMed ID: 17340621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A biochemical mechanism for resistance of intervertebral discs to metastatic cancer: Fas ligand produced by disc cells induces apoptotic cell death of cancer cells.
    Park JB; Lee JK; Cho ST; Park EY; Riew KD
    Eur Spine J; 2007 Sep; 16(9):1319-24. PubMed ID: 17684774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas/FasL-dependent and -independent activation of caspase-8 in doxorubicin-treated human breast cancer MCF-7 cells: ADAM10 down-regulation activates Fas/FasL signaling pathway.
    Liu WH; Chang LS
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1708-19. PubMed ID: 21854868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis.
    Yu W; Israel K; Liao QY; Aldaz CM; Sanders BG; Kline K
    Cancer Res; 1999 Feb; 59(4):953-61. PubMed ID: 10029090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of apoptosis in human colorectal tumor cells exposed to capecitabine, Xeloda, is mediated via Fas.
    Ciccolini J; Fina F; Bezulier K; Giacometti S; Roussel M; Evrard A; Cuq P; Romain S; Martin PM; Aubert C
    Mol Cancer Ther; 2002 Sep; 1(11):923-7. PubMed ID: 12481413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivated Sendai virus strain Tianjin induces apoptosis in breast cancer MCF-7 cells by promoting caspase activation and Fas/FasL expression.
    Shi LY; Han Z; Li XX; Li M; Han H; Chen J; Zang S
    Cancer Biother Radiopharm; 2015 Feb; 30(1):33-40. PubMed ID: 25517620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction.
    Li S; Zhou Y; Dong Y; Ip C
    Anticancer Res; 2007; 27(5A):3075-82. PubMed ID: 17970047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death receptor-dependent and -independent pathways in anticancer drug-induced apoptosis of breast cancer cells.
    Kim R; Tanabe K; Emi M; Uchida Y; Toge T
    Oncol Rep; 2003; 10(6):1925-30. PubMed ID: 14534720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoclasts direct bystander killing of cancer cells in vitro.
    Ramnaraine M; Pan W; Clohisy DR
    Bone; 2006 Jan; 38(1):4-12. PubMed ID: 16139579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
    Ruiz-Ruiz MC; López-Rivas A
    Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifeguard inhibition of Fas-mediated apoptosis: A possible mechanism for explaining the cisplatin resistance of triple-negative breast cancer cells.
    Radin D; Lippa A; Patel P; Leonardi D
    Biomed Pharmacother; 2016 Feb; 77():161-6. PubMed ID: 26796280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
    Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T
    Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells.
    Zhu Q; Liu JY; Yang CM; Xu HW; Zhang AZ; Cui Y; Wang HB; Qin CY; Li YQ
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1071-7. PubMed ID: 16957513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel camptothecin derivative, CPT211, induces cell cycle arrest and apoptosis in models of human breast cancer.
    Chiu CF; Lin YQ; Park JM; Chen YC; Hung SW; Chiu CC; Chang CF
    Biomed Pharmacother; 2020 Aug; 128():110309. PubMed ID: 32505820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
    Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
    Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New compound NL-608 (a nutlin analog) induces apoptosis in human breast cancer MCF-7 cells].
    Ge YK; Zhang YX; Chen YP; Bai X; Shi W
    Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):100-3. PubMed ID: 22780926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression.
    Hyer ML; Sudarshan S; Schwartz DA; Hannun Y; Dong JY; Norris JS
    Cancer Gene Ther; 2003 Apr; 10(4):330-9. PubMed ID: 12679806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.